Childhood influenza-vaccination coverage--United States, 2002-03 influenza season

    Insights

    Influenza vaccination coverage for young children (6-23 months) was low during the first year of recommendation. Significant state and urban variations in childhood flu vaccine uptake were observed.

    Area of Science:

    • Pediatric Public Health
    • Vaccinology
    • Epidemiology

    Background:

    • Young children under 2 years old face a higher risk of hospitalization due to influenza.
    • The Advisory Committee on Immunization Practices (ACIP) began recommending annual influenza vaccinations for children aged 6-23 months and their close contacts in 2002, strengthening this to a formal recommendation in 2004-05.
    • Vaccination is also recommended for children aged 6 months to 18 years with high-risk medical conditions and their household contacts.

    Purpose of the Study:

    • To establish a baseline for childhood influenza vaccination coverage for the 2002-03 season.
    • To assess the initial impact of the ACIP encouragement for vaccinating children aged 6-23 months.
    • To identify variations in vaccination coverage among different geographic areas.

    Main Methods:

    • Analysis of childhood influenza vaccination coverage data for the 2002-03 season.
    • Examination of vaccination rates among children aged 6-23 months.
    • Comparison of coverage across different states and urban areas.

    Main Results:

    • Influenza vaccination coverage among children aged 6-23 months was low in the first year of the ACIP encouragement.
    • Substantial variability in vaccination coverage was noted between different states.
    • Significant differences in vaccination uptake were also observed among various urban areas.

    Conclusions:

    • The initial year of the ACIP encouragement for childhood influenza vaccination showed low uptake among the target age group.
    • Geographic disparities in vaccination coverage highlight the need for targeted interventions.
    • Further efforts are required to improve influenza vaccine accessibility and uptake in young children.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Chickenpox01:20

    Chickenpox

    Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...